BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6159767)

  • 1. Serum beta 2-microglobulin, serum creatinine and bone marrow plasma cells in benign and malignant monoclonal gammopathy.
    Morell A; Riesen W
    Acta Haematol; 1980; 64(2):87-93. PubMed ID: 6159767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum beta 2-microglobulin in patients with monoclonal gammopathies.
    Di Giovanni S; Valentini G; Ravazzolo E; Carducci P; Giallonardo P; Maschio C
    Int J Biol Markers; 1987; 2(3):169-72. PubMed ID: 3131451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation between benign and malignant monoclonal gammopathies by discriminant analysis on serum and bone marrow parameters.
    Morell A; Maurer W; Skvaril F; Barandun S
    Acta Haematol; 1978; 60(3):129-36. PubMed ID: 101000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the origin of the precursor cells in multiple myeloma, Waldenström's macroglobulinaemia and benign monoclonal gammopathy. I. Cytoplasmic isotype and idiotype distribution in peripheral blood and bone marrow.
    Van Camp B; Reynaert P; Broodtaerts L
    Clin Exp Immunol; 1981 Apr; 44(1):82-9. PubMed ID: 6790210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Benign' monoclonal gammopathy. A misnomer?
    Kyle RA
    JAMA; 1984 Apr; 251(14):1849-54. PubMed ID: 6422066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoplasmic immunoglobulins in bone marrow cells of polyclonal and of monoclonal origin.
    Morell A; Skvaril F; Huser HJ; Spengler G; Barandun S
    Acta Haematol; 1978; 60(3):137-47. PubMed ID: 101001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of correlation between plasma cell thymidine labelling index and serum beta-2-microglobulin in monoclonal gammopathies.
    Boccadoro M; Durie BG; Frutiger Y; Gavarotti P; Redoglia V; Massaia M; D'Alberto M; Marmont F; Gallamini A; Tribalto M
    Acta Haematol; 1987; 78(4):239-42. PubMed ID: 3122489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of serum beta 2-microglobulin in the differential diagnosis of benign and malignant M-globulinemia].
    Wu YF; Zhu JZ
    Zhonghua Nei Ke Za Zhi; 1989 May; 28(5):265-6, 313. PubMed ID: 2509168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies of peripheral blood lymphocytes subpopulation in multiple myeloma, Waldenström's macroglobulinemia and benign monoclonal gammopathy (author's transl)].
    Matsuda S; Kimura H; Tanaka T; Akizuki T; Yoshida H; Uchida T; Kariyone S
    Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):485-92. PubMed ID: 99942
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum ferritin and beta-2-microglobulin in multiple myeloma].
    Linkesch W; Ludwig H
    Acta Med Austriaca; 1982; 9(5-6):227-31. PubMed ID: 6187172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
    Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
    Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum neopterin and beta 2-microglobulin concentrations in monoclonal gammopathies.
    Fine JM; Lambin P; Desjobert H
    Acta Med Scand; 1988; 224(2):179-82. PubMed ID: 3048055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy-specific beta 1-glycoprotein in serum in monoclonal gammopathies: relationship with serum beta 2-microglobulin, and cellular origin.
    Fagnart OC; Tasiaux N; Masson PL
    Clin Chem; 1986 Dec; 32(12):2150-4. PubMed ID: 3096609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum beta-2-microglobulin in multiple myeloma. Practical value].
    Bataille R; Magub M; Sany J; Donadio D; Izarn P; Grenier J; Suquet P
    Rev Rhum Mal Osteoartic; 1981 Mar; 48(3):235-40. PubMed ID: 6164091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of myeloma cells by means of labeling index, bone marrow histology, and serum beta 2-microglobulin.
    Schambeck CM; Bartl R; Höchtlen-Vollmar W; Wick M; Lamerz R; Fateh-Moghadam A
    Am J Clin Pathol; 1996 Jul; 106(1):64-8. PubMed ID: 8701935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular manifestations of multiple myeloma, Waldenström's macroglobulinemia and benign monoclonal gammopathy.
    Orellana J; Friedman AH
    Surv Ophthalmol; 1981; 26(3):157-69. PubMed ID: 6801795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between bone marrow angiogenesis and plasma cell infiltration and serum beta2-microglobulin levels in patients with multiple myeloma.
    Sezer O; Niemöller K; Jakob C; Zavrski I; Heider U; Eucker J; Kaufmann O; Possinger K
    Ann Hematol; 2001 Oct; 80(10):598-601. PubMed ID: 11732871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine B2-microglobulin in patients with macroglobulinemia Waldenström.
    Engström W; Wahrgren P
    Clin Chim Acta; 1980 Jul; 105(1):123-6. PubMed ID: 6156780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma cholesterol concentration and extra lipid band in monoclonal gammopathies.
    Levy Y; Aviram M; Spira G; Tatarsky I; Brook GJ; Carter A
    Postgrad Med J; 1984 Jul; 60(705):449-53. PubMed ID: 6431399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenström's macroglobulinemia.
    Gertz MA; Kyle RA; Noel P
    J Clin Oncol; 1993 May; 11(5):914-20. PubMed ID: 8487054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.